DW

Dan Wu

Scientific Founder (Yale University)

Qx Therapeutics

Qx Therapeutics Pipeline

DrugIndicationPhase
QXT-101Pulmonary Graft Dysfunction (PGD) following Lung TransplantationPhase 2